Pluristem Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pluristem Therapeutics

PSTI 8.720

+0.2%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: xcentral1	9/26/2008 8:57:57 AM
	of 295

Pluristem raises $1m in private placement: The company expects to begin clinical trials this year for its product for new blood vessel growth this year. Sep 25, 2008 (Globes - McClatchy-Tribune News Service via COMTEX) -- Sep. 25--Biotherapeutics company Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT) has raised $1 million in a private placement held at a 44 percent premium on its market price. The placement comprises 900,000 shares at $1.15 per share and a five year warrant for 675,000 shares at a strike price of $1.90. The company did not disclose the investor. Pluristem rose 4.5 percent yesterday to $0.93, giving a market cap of $6.4 million. The company expects to begin clinical trials this year for its PLX-PAD cellular product for new blood vessel growth for the treatment of critical limb ischemia, caused by Peripheral Artery Disease.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next